Novartis | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 1.66B 3.15B 2025-03
Amgen USD 1.97B 1.41B 2025-03
AstraZeneca USD 3.13B 275M 2025-06
Bausch Health Companies USD 140M 187M 2025-06
Biogen USD 744M 432.8M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 31.69M 22.07M 2025-06
Drreddys Laboratories 18.74B 431M 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 1.89B 221M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
J&J USD 13.63B 8.21B 2025-03
Merck USD 6.77B 864M 2025-06
Novartis USD 4.53B 124M 2025-06
Novartis USD 4.66B 269M 2024-12
Pacira USD 8.71M 16.82M 2025-03
Perrigo USD 8.3M 143M 2025-03
Pfizer USD 2.78B 1.65B 2025-03
Prestige Brands USD 73.96M 6.19M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
Sanofi USD 2.32B 2.64B 2024-12
Supernus Pharmaceuticals USD 16.67M 22.5M 2025-06
Zoetis USD 810M 37M 2025-03


Novartis L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.